Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial.

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Mukherjee, S.
  • Hurt, C.
  • Cox, C.
  • Radhakrishna, G.
  • Gwynne, S.
  • Bateman, A.R.
  • Gollins, S.
  • Hawkins, M.A.
  • Canham, J.
  • Grabsch, H.I.
  • Falk, S.
  • Sharma, R.A.
  • Ray, R.
  • Roy, R.
  • Wade, W.
  • Maggs, R.
  • Sebag-Montefiore, D.J. ORCID logo https://orcid.org/0000-0002-5978-9259
  • Maughan, T.
  • Griffiths, G.O.
  • Crosby, T.D.L.
Dates:
  • Published: February 2020
  • Published (online): 4 February 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Depositing User: Symplectic Publications
Date Deposited: 31 Jul 2024 14:57
Last Modified: 31 Jul 2024 14:57
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: 10.1200/jco.2020.38.4_suppl.373
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)